In this episode, we explore new international guidelines for clozapine monitoring following the FDA's REMS rescission. Should patients on stable clozapine continue lifelong monthly blood draws, or can we safely reduce monitoring after two years? Dr. Seeber discusses how these evidence-based recommendations balance patient burden with safety. Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 79 New Guidelines for Clozapine ANC Monitoring
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Prescribing Through Pregnancy: Dosing, Levels, and Relapse Risk
Bright Light Therapy for Bipolar Depression
Lithium: Managing Cosmetic and Sexual Side Effects
KarXT: A New Era in Antipsychotics?
Free AI-powered recaps of Psychopharmacology and Psychiatry Updates and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.